Answers are grounded in this paper and cite their sources.
To investigate the association between serum 25-hydroxyvitamin D (25(OH)D) and adenoid hypertrophy (AH) in children, exploring potential age-related effect modification and the role of serum total IgE. We retrospectively analyzed 438 children (3–12 years) presenting with sleep-disordered breathing. Patients were grouped by endoscopic choanal obstruction into AH (choanal obstruction ≥ 51%, n = 325) and symptomatic clinical comparison (≤ 50%, n = 113) groups. Multivariable and Firth penalized logistic regressions assessed 25(OH)D-AH associations overall and in age-stratified subgroups (preschool: <7 years, n = 39; school-age: ≥7 years, n = 399). Formal 25(OH)D-age interaction and an exploratory IgE subset ( n = 131) were evaluated. Overall, 25(OH)D showed a non-significant inverse trend with AH (OR = 0.975 per 1 ng/mL, P = 0.081; approximately 0.78 per 10 ng/mL). In Firth regression, higher 25(OH)D was nominally associated with lower AH odds in preschool (OR = 0.927, P = 0.032), but not school-age children (OR = 0.976, P = 0.115). However, 25(OH)D-age interaction was non-significant (age group: P = 0.523; continuous: P = 0.307), and the nominal preschool association did not retain statistical significance after excluding high-leverage observations (OR = 0.920, 95% CI 0.820–1.013, P = 0.090). Serum total IgE levels did not differ significantly between groups ( P = 0.260). In symptomatic children, 25(OH)D showed a non-significant inverse association with AH (OR = 0.975 per 1 ng/mL, approximately 0.78 per 10 ng/mL). The nominal preschool association was not supported by age-interaction testing or sensitivity analyses. These hypothesis-generating findings do not support routine 25(OH)D screening or supplementation for AH management. Future prospective studies are required.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: